Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657486 · ClinicalTrials.gov registry record · NA
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02657486: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02657486 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657486, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to study the activity and effects of BGJ398 on bladder cancer tumors that are confined to the lining of the bladder.
Interventions
- DRUG BGJ398
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-01-06 |
| Est. Completion | 2026-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02657486
The ClinicalTrials.gov registry entry for NCT02657486 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BGJ398 is the first listed.
NCT02657486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02657486 about?
NCT02657486 is a clinical study titled "BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder". The purpose of this study is to study the activity and effects of BGJ398 on bladder cancer tumors that are confined to the lining of the bladder.
What is the current status of trial NCT02657486?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2016-01-06. Estimated completion is 2026-02-04.
What interventions are being tested in trial NCT02657486?
The interventions under investigation include: BGJ398 (DRUG).
Who is sponsoring clinical trial NCT02657486?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.